NOT KNOWN FACTUAL STATEMENTS ABOUT HEMGENIX

Variety of eligible sufferers: CDEC talked about the uncertainty in the quantity of clients with reasonably critical to intense hemophilia B in Canada suitable for etranacogene dezaparvovec. Medical professionals consulted by CADTH indicated that some sufferers who're classified as getting mild or average disorder could possibly have a significant